Answers are grounded in this paper and cite their sources.
Analysis shows elevated lactate dehydrogenase-to-albumin ratio predicts respiratory mortality in cancer survivors, indicating a need for early intervention.
Respiratory disease is a leading cause of death among cancer survivors. Using NHANES 2007–2012 data (15,854 participants, 1472 with cancer), we examined whether the lactate-dehydrogenase-to-albumin ratio (LAR) predicts respiratory mortality. LAR was calculated as LDH (U/L) divided by serum albumin (g/L), and participants were categorized into quintiles. The study found that higher LAR levels were positively correlated with increased all-cause and respiratory disease mortality. Specifically, participants in the highest LAR quintile had a 43% higher risk of all-cause mortality and a significantly higher risk of respiratory disease mortality (hazard ratio = 4.87, 95% confidence interval: 1.25–18.9). These data indicate that LAR may serve as an easily available prognostic marker to flag cancer survivors at high risk of fatal respiratory events, informing targeted surveillance and early intervention.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: